Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas

José Villacorta Hidalgo, Peter Bronsert, Marzenna Orlowska‐Volk, Liliana B. Díaz, Elmar Stickeler, Martin Werner, Annette Schmitt‐Graeff, Gian Kayser, Miroslav Malkovský, Paul FischFrontiers in Immunology 2014 · DOI

Abstract

Breast cancer is the leading cause of cancer death in women and the second most common cancer worldwide. Triple-negative breast carcinomas (TNBCs) lack expression of HER2 and the estrogen and progesterone receptors and often contain lymphocytic infiltrates. Most TNBCs are invasive ductal carcinomas (IDCs) with poor prognosis, whereas medullary breast carcinomas (MBCs) are prognostically more favorable. While infiltrating T-cells are associated with improved clinical outcomes in TNBCs, the prognostic role of γδ T-cells remains unclear. We analyzed 26 TNBCs (14 IDCs and 12 MBCs) using immunohistochemistry to assess the quantity and patterns of γδ T-cell infiltrates. We found higher numbers of γδ T-cells in TNBCs compared to normal breast tissues and fibroadenomas. Notably, γδ T-cell counts were higher in MBCs than in IDCs. In MBCs, these cells were frequently in direct contact with tumor cells, whereas in IDCs, they were primarily found in clusters within the stroma. These findings suggest that the spatial distribution of γδ T-cells may correlate with the better prognosis observed in MBCs.

Introduction

Triple-negative breast cancer (TNBC) is a notoriously aggressive form of cancer that lacks the three most common receptors—estrogen, progesterone, and HER2—used for targeted therapy. Within the TNBC umbrella, a clinical paradox exists: Invasive Ductal Carcinomas (IDC) typically have a poor prognosis, while Medullary Breast Carcinomas (MBC) often have a much better clinical outcome despite their aggressive histological appearance.

Tumor-infiltrating lymphocytes (TILs) are known to play a role in this difference, but most research focuses on standard αβ T-cells. This study investigates the less-understood γδ T-cells. These cells are unique because they can recognize and kill tumor cells without the complex MHC-matching process required by standard T-cells. The authors sought to determine if the quantity and location of these γδ T-cells could explain the prognostic differences between TNBC subtypes.

Methods

The researchers performed a retrospective histological study using 26 TNBC specimens (14 IDCs and 12 MBCs) from the University of Freiburg, along with control groups of normal tissue and fibroadenomas.

  • Immunohistochemistry (IHC): Specific antibodies were used to visualize cell types. Crucially, the mAb γ3.20 antibody allowed for the detection of γδ T-cells in standard paraffin-embedded (FFPE) clinical samples.
  • Markers: Samples were stained for CD3 (all T-cells), TCRγδ (the subset of interest), and cleaved-caspase-3 (CC3) (a marker for apoptosis).
  • Quantification: Two independent investigators manually counted cells across 20 high-power fields (HPF) per sample.

Results

The analysis revealed that γδ T-cells are specifically recruited to the tumor microenvironment, as they were nearly absent in healthy breast tissue and benign fibroadenomas.

Quantitative Differences

MBCs exhibited significantly higher numbers of γδ T-cells in the tumor parenchyma, with a mean of 8 per HPF compared to 2 per HPF in IDCs. This higher density in MBCs correlated with increased tumor cell death, as MBCs showed nearly double the rate of apoptotic tumor cells (7 per HPF) compared to IDCs (4 per HPF).

Spatial Distribution: The "Stuck in the Stroma" Phenomenon

A key finding was the difference in spatial distribution. In the poorer-prognosis IDC samples, γδ T-cells were mostly found in clusters within the stroma (supportive tissue). In contrast, in MBCs, these cells were actively infiltrating the parenchyma (tumor mass) and were frequently in direct physical contact with tumor cells.

Figure 6: Immunohistochemical staining of TNBC tissue. (A) CD3+ T-cell infiltration (100x). (B) TCRγδ+ T-cell infiltration in the same area (100x). (C) High-magnification (200x) view of TCRγδ+ cells showing direct contact with tumor cells.

Discussion

The recruitment of γδ T-cells to TNBCs suggests they are part of a specialized defense against aggressive cancers. The direct contact between these cells and tumor cells in MBCs, coupled with higher apoptosis rates, hints at a functional link between γδ T-cell infiltration and tumor destruction. Conversely, the sequestration of these cells in the stroma of IDCs may represent an immune evasion mechanism or a failure of recruitment into the tumor core, potentially explaining the poorer prognosis.

Conclusion and Future Work

While limited by sample size, this study highlights the potential prognostic value of γδ T-cell infiltration patterns. The researchers are currently using microdissection and single-cell PCR to analyze the gene expression of these cells. Understanding the specific molecular subsets of γδ T-cells could lead to new immunotherapy strategies for TNBC patients.

Summary updated

Abstract

Breast cancer is the leading cause of cancer death in women and the second most common cancer worldwide after lung cancer. The remarkable heterogeneity of breast cancers influences numerous diagnostic, therapeutic, and prognostic factors. Triple-negative breast carcinomas (TNBCs) lack expression of HER2 and the estrogen and progesterone receptors and often contain lymphocytic infiltrates. Most of TNBCs are invasive ductal carcinomas (IDCs) with poor prognosis, whereas prognostically more favorable subtypes such as medullary breast carcinomas (MBCs) are somewhat less frequent. Infiltrating T-cells have been associated with an improved clinical outcome in TNBCs. The prognostic role of γδ T-cells within CD3(+) tumor-infiltrating T lymphocytes remains unclear. We analyzed 26 TNBCs, 14 IDCs, and 12 MBCs, using immunohistochemistry for the quantity and patterns of γδ T-cell infiltrates within the tumor microenvironment. In both types of TNBCs, we found higher numbers of γδ T-cells in comparison with normal breast tissues and fibroadenomas. The numbers of infiltrating γδ T-cells were higher in MBCs than in IDCs. γδ T-cells in MBCs were frequently located in direct contact with tumor cells, within the tumor and at its invasive border. In contrast, most γδ T-cells in IDCs were found in clusters within the tumor stroma. These findings could be associated with the fact that the patient's prognosis in MBCs is better than that in IDCs. Further studies to characterize these γδ T-cells at the molecular and functional level are in progress.
BibTeX
@inproceedings{hidalgo2014histological,
  author = {José Villacorta Hidalgo and Peter Bronsert and Marzenna Orlowska‐Volk and Liliana B. Díaz and Elmar Stickeler and Martin Werner and Annette Schmitt‐Graeff and Gian Kayser and Miroslav Malkovský and Paul Fisch},
  title = {{Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas}},
  booktitle = {Frontiers in Immunology},
  year = {2014},
  doi = {10.3389/fimmu.2014.00632},
}
Figure